Clinicopathological indices to predict hepatocellular carcinoma molecular classification

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is the second most lethal cancer due to lack of effective therapies. Although promising, HCC molecular classification, which enriches potential responders to specific therapies, has not yet been assessed in clinical trials of anti-HCC drugs. We a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Liver Int
Главные авторы: Tan, Poh Seng, Nakagawa, Shigeki, Goossens, Nicolas, Venkatesh, Anu, Huang, Tiangui, Ward, Stephen C., Sun, Xiaochen, Song, Won-Min, Koh, Anna, Canasto-Chibuque, Claudia, Deshmukh, Manjeet, Nair, Venugopalan, Mahajan, Milind, Zhang, Bin, Fiel, Maria Isabel, Kobayashi, Masahiro, Kumada, Hiromitsu, Hoshida, Yujin
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674393/
https://ncbi.nlm.nih.gov/pubmed/26058462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.12889
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы